The immunophenotypic stability of plasma cell myeloma by flow cytometry

M. D. Spears, Horatiu Olteanu, S. H. Kroft, A. M. Harrington

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Introduction: Flow cytometry (FC) has become increasingly utilized in the diagnosis and monitoring of plasma cell myeloma (PCM), though few studies have evaluated the longitudinal stability of antigen expression. Methods: We studied 45 PCM patients by four-color FC for shifts in CD19, CD20, CD38, CD45, CD56, and cytoplasmic light chain expression, between diagnostic/first encounter and positive follow-up analyses. An immunophenotypic (IP) change was defined as gain, loss, or 1/2 log shift of antigen expression. Results: An IP change was observed in 14/45 (31%) patients, with single IP changes in 9/14, two changes in 2/14, and three changes in 3/14. 3/14 reverted from an aberrant to a normal plasma cell IP, while remaining light chain-restricted. Changes in expression of CD45 occurred in 9/45 (20%), CD19 in 5/45 (11.1%), CD20 in 2/45 (4.4%), and CD56 in 5/45 (11.1%). Conclusion: Approximately 1/3 of PCM cases show IP changes over time, with CD45 the least stable antigen. Recognition of this relative instability is important to avoid narrow targeting of follow-up FC analyses, especially for minimal residual disease monitoring.

Original languageEnglish (US)
Pages (from-to)483-491
Number of pages9
JournalInternational Journal of Laboratory Hematology
Volume33
Issue number5
DOIs
StatePublished - Oct 1 2011
Externally publishedYes

Fingerprint

Flow cytometry
Multiple Myeloma
Flow Cytometry
Plasmas
Antigens
Light
Residual Neoplasm
Plasma Cells
Monitoring
Color

Keywords

  • Flow cytometry
  • Immunophenotype
  • Minimal residual disease
  • Plasma cell myeloma
  • Stability

ASJC Scopus subject areas

  • Hematology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

The immunophenotypic stability of plasma cell myeloma by flow cytometry. / Spears, M. D.; Olteanu, Horatiu; Kroft, S. H.; Harrington, A. M.

In: International Journal of Laboratory Hematology, Vol. 33, No. 5, 01.10.2011, p. 483-491.

Research output: Contribution to journalArticle

Spears, M. D. ; Olteanu, Horatiu ; Kroft, S. H. ; Harrington, A. M. / The immunophenotypic stability of plasma cell myeloma by flow cytometry. In: International Journal of Laboratory Hematology. 2011 ; Vol. 33, No. 5. pp. 483-491.
@article{e54ff2a2720b4c5884f5eaffd05218d1,
title = "The immunophenotypic stability of plasma cell myeloma by flow cytometry",
abstract = "Introduction: Flow cytometry (FC) has become increasingly utilized in the diagnosis and monitoring of plasma cell myeloma (PCM), though few studies have evaluated the longitudinal stability of antigen expression. Methods: We studied 45 PCM patients by four-color FC for shifts in CD19, CD20, CD38, CD45, CD56, and cytoplasmic light chain expression, between diagnostic/first encounter and positive follow-up analyses. An immunophenotypic (IP) change was defined as gain, loss, or 1/2 log shift of antigen expression. Results: An IP change was observed in 14/45 (31{\%}) patients, with single IP changes in 9/14, two changes in 2/14, and three changes in 3/14. 3/14 reverted from an aberrant to a normal plasma cell IP, while remaining light chain-restricted. Changes in expression of CD45 occurred in 9/45 (20{\%}), CD19 in 5/45 (11.1{\%}), CD20 in 2/45 (4.4{\%}), and CD56 in 5/45 (11.1{\%}). Conclusion: Approximately 1/3 of PCM cases show IP changes over time, with CD45 the least stable antigen. Recognition of this relative instability is important to avoid narrow targeting of follow-up FC analyses, especially for minimal residual disease monitoring.",
keywords = "Flow cytometry, Immunophenotype, Minimal residual disease, Plasma cell myeloma, Stability",
author = "Spears, {M. D.} and Horatiu Olteanu and Kroft, {S. H.} and Harrington, {A. M.}",
year = "2011",
month = "10",
day = "1",
doi = "10.1111/j.1751-553X.2011.01317.x",
language = "English (US)",
volume = "33",
pages = "483--491",
journal = "International Journal of Laboratory Hematology",
issn = "1751-5521",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - The immunophenotypic stability of plasma cell myeloma by flow cytometry

AU - Spears, M. D.

AU - Olteanu, Horatiu

AU - Kroft, S. H.

AU - Harrington, A. M.

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Introduction: Flow cytometry (FC) has become increasingly utilized in the diagnosis and monitoring of plasma cell myeloma (PCM), though few studies have evaluated the longitudinal stability of antigen expression. Methods: We studied 45 PCM patients by four-color FC for shifts in CD19, CD20, CD38, CD45, CD56, and cytoplasmic light chain expression, between diagnostic/first encounter and positive follow-up analyses. An immunophenotypic (IP) change was defined as gain, loss, or 1/2 log shift of antigen expression. Results: An IP change was observed in 14/45 (31%) patients, with single IP changes in 9/14, two changes in 2/14, and three changes in 3/14. 3/14 reverted from an aberrant to a normal plasma cell IP, while remaining light chain-restricted. Changes in expression of CD45 occurred in 9/45 (20%), CD19 in 5/45 (11.1%), CD20 in 2/45 (4.4%), and CD56 in 5/45 (11.1%). Conclusion: Approximately 1/3 of PCM cases show IP changes over time, with CD45 the least stable antigen. Recognition of this relative instability is important to avoid narrow targeting of follow-up FC analyses, especially for minimal residual disease monitoring.

AB - Introduction: Flow cytometry (FC) has become increasingly utilized in the diagnosis and monitoring of plasma cell myeloma (PCM), though few studies have evaluated the longitudinal stability of antigen expression. Methods: We studied 45 PCM patients by four-color FC for shifts in CD19, CD20, CD38, CD45, CD56, and cytoplasmic light chain expression, between diagnostic/first encounter and positive follow-up analyses. An immunophenotypic (IP) change was defined as gain, loss, or 1/2 log shift of antigen expression. Results: An IP change was observed in 14/45 (31%) patients, with single IP changes in 9/14, two changes in 2/14, and three changes in 3/14. 3/14 reverted from an aberrant to a normal plasma cell IP, while remaining light chain-restricted. Changes in expression of CD45 occurred in 9/45 (20%), CD19 in 5/45 (11.1%), CD20 in 2/45 (4.4%), and CD56 in 5/45 (11.1%). Conclusion: Approximately 1/3 of PCM cases show IP changes over time, with CD45 the least stable antigen. Recognition of this relative instability is important to avoid narrow targeting of follow-up FC analyses, especially for minimal residual disease monitoring.

KW - Flow cytometry

KW - Immunophenotype

KW - Minimal residual disease

KW - Plasma cell myeloma

KW - Stability

UR - http://www.scopus.com/inward/record.url?scp=80051926755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051926755&partnerID=8YFLogxK

U2 - 10.1111/j.1751-553X.2011.01317.x

DO - 10.1111/j.1751-553X.2011.01317.x

M3 - Article

C2 - 21470371

AN - SCOPUS:80051926755

VL - 33

SP - 483

EP - 491

JO - International Journal of Laboratory Hematology

JF - International Journal of Laboratory Hematology

SN - 1751-5521

IS - 5

ER -